HER2 Amplification and HER2 Mutation Are Distinct Molecular Targets in Lung Cancers von Li, Bob T., Ross, Dara S., Aisner, Dara L., Chaft, Jamie E., Hsu, Meier, Kako, Severine L., Kris, Mark G., Varella-Garcia, Marileila, Arcila, Maria E.

Volltext

Histopathologic features and molecular genetic landscape of HER2-amplified endometrial carcinomas von Ross, Dara S., Devereaux, Kelly A., Jin, Cao, Lin, David YunTe, Zhang, Yanming, Marra, Antonio, Makker, Vicky, Weigelt, Britta, Ellenson, Lora H., Chui, M. Herman

Volltext

FOXA1 Mutations Reveal Distinct Chromatin Profiles and Influence Therapeutic Response in Breast Cancer von Arruabarrena-Aristorena, Amaia, Maag, Jesper L.V., Kittane, Srushti, Cai, Yanyan, Karthaus, Wouter R., Ladewig, Erik, Park, Jane, Kannan, Srinivasaraghavan, Ferrando, Lorenzo, Cocco, Emiliano, Ho, Sik Y., Tan, Daisylyn S., Sallaku, Mirna, Wu, Fan, Acevedo, Barbara, Selenica, Pier, Ross, Dara S., Witkin, Matthew, Sawyers, Charles L., Reis-Filho, Jorge S., Verma, Chandra S., Jauch, Ralf, Koche, Richard, Baselga, José, Razavi, Pedram, Toska, Eneda, Scaltriti, Maurizio

Volltext

Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid... von Cheng, Donavan T, Mitchell, Talia N, Zehir, Ahmet, Shah, Ronak H, Benayed, Ryma, Syed, Aijazuddin, Chandramohan, Raghu, Liu, Zhen Yu, Won, Helen H, Scott, Sasinya N, Brannon, A Rose, O'Reilly, Catherine, Sadowska, Justyna, Casanova, Jacklyn, Yannes, Angela, Hechtman, Jaclyn F, Yao, Jinjuan, Song, Wei, Ross, Dara S, Oultache, Alifya, Dogan, Snjezana, Borsu, Laetitia, Hameed, Meera, Nafa, Khedoudja, Arcila, Maria E, Ladanyi, Marc, Berger, Michael F

Volltext

KIT genetic alterations in breast cancer von Vahdatinia, Mahsa, Derakhshan, Fatemeh, Da Cruz Paula, Arnaud, Dopeso, Higinio, Marra, Antonio, Gazzo, Andrea M, Brown, David, Selenica, Pier, Ross, Dara S, Razavi, Pedram, Zhang, Hong, Weigelt, Britta, Wen, Hannah Y, Brogi, Edi, Reis-Filho, Jorge S, Pareja, Fresia

Volltext

Pathologic complete response rate according to HER2 detection methods in HER2-positive breast cancer treated with neoadjuvant systemic therapy von Krystel-Whittemore, Melissa, Xu, Jin, Brogi, Edi, Ventura, Katia, Patil, Sujata, Ross, Dara S., Dang, Chau, Robson, Mark, Norton, Larry, Morrow, Monica, Wen, Hannah Y.

Volltext

Identification of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer by Using HER2-targeted 89Zr-Pertuzumab PET/CT von Ulaner, Gary A., Carrasquillo, Jorge A., Riedl, Christopher C., Yeh, Randy, Hatzoglou, Vaios, Ross, Dara S., Jhaveri, Komal, Chandarlapaty, Sarat, Hyman, David M., Zeglis, Brian M., Lyashchenko, Serge K., Lewis, Jason S.

Volltext

HER2 + breast cancers evade anti-HER2 therapy via a switch in driver pathway von Smith, Alison E., Ferraro, Emanuela, Safonov, Anton, Morales, Cristina Bernado, Lahuerta, Enrique J. Arenas, Li, Qing, Kulick, Amanda, Ross, Dara, Solit, David B., de Stanchina, Elisa, Reis-Filho, Jorge, Rosen, Neal, Arribas, Joaquín, Razavi, Pedram, Chandarlapaty, Sarat

Volltext

Multiple cancer/testis antigens are preferentially expressed in hormone-receptor negative and high-grade breast cancers von Chen, Yao-Tseng, Ross, Dara S, Chiu, Rita, Zhou, Xi K, Chen, Yunn-Yi, Lee, Peishan, Hoda, Syed A, Simpson, Andrew J, Old, Lloyd J, Caballero, Otavia, Neville, A Munro

Volltext

HER2 Immunohistochemistry in Invasive Micropapillary Breast Carcinoma: Complete Assessment of an Incomplete Pattern von Perron, Marjorie, Wen, Hannah Y., Hanna, Matthew G., Brogi, Edi, Ross, Dara S.

Volltext

ERBB2 amplification status in 67 salivary duct carcinomas assessed by immunohistochemistry, fluorescence in situ hybridization, and targeted exome sequencing von Ferguson, Donna C., Momeni Boroujeni, Amir, Zheng, Tao, Mohanty, Abhinita S., Ho, Alan L., Arcila, Maria E., Ross, Dara S., Dogan, Snjezana

Volltext

Skin adnexal carcinoma with BRD3‐NUTM2B fusion von Rubio Gonzalez, Belen, Ortiz, Michael V., Ross, Dara S., Busam, Klaus J.

Volltext

Semi-automated analysis of HER2 immunohistochemistry in invasive breast carcinoma using whole slide images: utility for interpretation in clinical practice von Liao, Chiu-Hsiang Connie, Bakoglu, Nilay, Cesmecioglu, Emine, Hanna, Matthew, Pareja, Fresia, Wen, Hannah Y, D'Alfonso, Timothy M, Brogi, Edi, Yagi, Yukako, Ross, Dara S

Volltext

Androgen receptor splice variant-7 in breast cancer: clinical and pathologic correlations von Ferguson, Donna C., Mata, Douglas A., Tay, Timothy KY, Traina, Tiffany A., Gucalp, Ayca, Chandarlapaty, Sarat, D’Alfonso, Timothy M., Brogi, Edi, Mullaney, Kerry, Ladanyi, Marc, Arcila, Maria E., Benayed, Ryma, Ross, Dara S.

Volltext

E-cadherin immunohistochemical expression in invasive lobular carcinoma of the breast: correlation with morphology and CDH1 somatic alterations von Grabenstetter, Anne, Mohanty, Abhinita S., Rana, Satshil, Zehir, Ahmet, Brannon, A. Rose, D'Alfonso, Timothy M., DeLair, Deborah F., Tan, Lee K., Ross, Dara S.

Volltext

The impact of MYC gene amplification on the clinicopathological features and prognosis of radiation‐associated angiosarcomas of the breast von Kuba, Maria Gabriela, Xu, Bin, D’Angelo, Sandra P, Rosenbaum, Evan, Plitas, George, Ross, Dara S, Brogi, Edi, Antonescu, Cristina R

Volltext

HER2 Genetic Intratumor Heterogeneity Is Associated With Resistance to Trastuzumab and Trastuzumab Emtansine Therapy in Recurrent High-Grade Endometrial Cancer von Shen, Sherry, Ma, Weining, Brown, David, Da Cruz Paula, Arnaud, Zhou, Qin, Iaosonos, Alexia, Tessier-Cloutier, Basile, Ross, Dara S., Troso-Sandoval, Tiffany, Reis-Filho, Jorge S., Abu-Rustum, Nadeem, Zhang, Yanming, Ellenson, Lora H., Weigelt, Britta, Makker, Vicky, Chui, M. Herman

Volltext

The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers von Razavi, Pedram, Chang, Matthew T., Xu, Guotai, Bandlamudi, Chaitanya, Ross, Dara S., Vasan, Neil, Cai, Yanyan, Bielski, Craig M., Donoghue, Mark T.A., Jonsson, Philip, Penson, Alexander, Shen, Ronglai, Pareja, Fresia, Kundra, Ritika, Middha, Sumit, Cheng, Michael L., Zehir, Ahmet, Kandoth, Cyriac, Patel, Ruchi, Huberman, Kety, Smyth, Lillian M., Jhaveri, Komal, Modi, Shanu, Traina, Tiffany A., Dang, Chau, Zhang, Wen, Weigelt, Britta, Li, Bob T., Ladanyi, Marc, Hyman, David M., Schultz, Nikolaus, Robson, Mark E., Hudis, Clifford, Brogi, Edi, Viale, Agnes, Norton, Larry, Dickler, Maura N., Berger, Michael F., Iacobuzio-Donahue, Christine A., Chandarlapaty, Sarat, Scaltriti, Maurizio, Reis-Filho, Jorge S., Solit, David B., Taylor, Barry S., Baselga, José

Volltext

Adjuvant enzalutamide for the treatment of early-stage androgen-receptor positive, triple-negative breast cancer: a feasibility study von Walsh, Elaine M., Gucalp, Ayca, Patil, Sujata, Edelweiss, Marcia, Ross, Dara S., Razavi, Pedram, Modi, Shanu, Iyengar, Neil M., Sanford, Rachel, Troso-Sandoval, Tiffany, Gorsky, Mila, Bromberg, Jacqueline, Drullinsky, Pamela, Lake, Diana, Wong, Serena, DeFusco, Patricia Ann, Lamparella, Nicholas, Gupta, Ranja, Tabassum, Tasmila, Boyle, Leigh Ann, Arumov, Artavazd, Traina, Tiffany A.

Volltext

Contrast-enhanced mammography in the assessment of residual disease after neoadjuvant treatment von Hogan, Molly P., Horvat, Joao V., Ross, Dara S., Sevilimedu, Varadan, Jochelson, Maxine S., Kirstein, Laurie J., Goldfarb, Shari B., Comstock, Christopher E., Sung, Janice S.

Volltext